• Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us
Home
  • Biotech
    • Cell & Gene Therapy
    • Clinical Data
    • Venture Capital
    • Deals
  • Research
  • Medtech
    • Devices
    • Diagnostics
    • AI and Machine Learning
  • CRO
  • Special Reports
  • Trending
    • Biologics
    • Clinical Development
  • Fierce 50
    • Special Report
    • Awards Gala
  • Awards
    • CRO Awards
    • Innovation Awards
  • Resources
    • Fierce Events
    • Industry Events
    • Webinars
    • Podcasts
    • Whitepapers
    • Survey
  • Events
  • Subscribe
Home
Trending
Hamburger Menu Hamburger Menu
  • Biotech
    • Cell & Gene Therapy
    • Clinical Data
    • Venture Capital
    • Deals
  • Research
  • Medtech
    • Devices
    • Diagnostics
    • AI and Machine Learning
  • CRO
  • Special Reports
  • Trending
    • Biologics
    • Clinical Development
  • Fierce 50
    • Special Report
    • Awards Gala
  • Awards
    • CRO Awards
    • Innovation Awards
  • Resources
    • Fierce Events
    • Industry Events
    • Webinars
    • Podcasts
    • Whitepapers
    • Survey
  • Events
  • Subscribe
  • Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us

CureVac

New Zealand white rabbit drinking water
Research

mRNA therapy reduced post-surgery eye scarring in rabbits

The injected treatment used lipid nanoparticles to deliver an mRNA transcript into the eyes of rabbits.
Darren Incorvaia Nov 27, 2024 2:00pm
flu virus b cells influenza

GSK's mRNA flu vaccine finally bests tricky B strains in phase 2

Sep 12, 2024 4:52am
change direction new plan alter arrows move reprioritize

CureVac gains $430M GSK vaccine contract, loses 30% of staff

Jul 3, 2024 5:00am
parachute mountains sunset clouds

Xaira, Anthos, CureVac & more—Chutes & Ladders

Apr 26, 2024 8:30am
Road block challenges clinical hold problems

CureVac, chasing Moderna mRNA flu shot, hits similar problems

Apr 4, 2024 9:30am
mRNA vaccine

CureVac touts COVID-19 vax data despite adverse events

Jan 5, 2024 11:16am

Home
  • Connect
    • The Team
    • Advertise
    • Marketing Kit
    • Let's Talk
  • Join Us
    • Newsletters
    • Resources
    • RSS Feeds
  • Our Brands
    • Fierce Pharma
    • Fierce Biotech
    • Fierce Healthcare
  • Our Events
    • Life Sciences Events
©2025 Questex LLC All rights reserved.
Terms of use
Privacy Policy
Privacy Settings